Occlutech GmbH
USPTO PatentsView assignee record - 35 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Occlutech ranks #9,097 of 49,997 tracked US assignees by granted-patent volume, with 35 patents across 9 technology areas.
- #9,097
- of 49,997 US assignees by volume
- Top 30%
- by Innovation Score (42.5/100)
- 16.9
- avg claims per patent
- -40%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R9097 · Foreign Corporation #9,097 · 35 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 35 grants
- UPPER-Q #9,097/49,997
- PHOTO-FINISH NeuroNexus
- CPC-NARROW A61B · 9 areas
- INNOV-PAR 42.5/100
- CLAIMS-RICH 16.9 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -40% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: NeuroNexus Technologies, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Occlutech’s 42.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Occlutech
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Altair Engineering · near
Altair Engineering · near
42 score
- Cambridge Silicon… · near
Cambridge Silicon… · near
42 score
- Crisi Medical Systems · near
Crisi Medical Systems · near
42 score
- Occlutech · this assignee
Occlutech · this assignee
42 score
- Patek Philippe Geneve · near
Patek Philippe Geneve · near
42 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Occlutech's Innovation Score is 42.5/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Occlutech?
Each dot is one of Occlutech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Occlutech’s own 16.9 claims/patent is ABOVE the 16.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Occlutech's grants concentrate
Occlutech GmbH is a focused PatentsView assignee: 9 CPC subclasses with 85.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2024. By volume, Occlutech sits between NeuroNexus Technologies, Inc. and Pluto Inc..
Occlutech's three-year grant acceleration
Occlutech GmbH shows 7 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Occlutech's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Neuronexus
NeuroNexus Technologies, Inc.
35 patents
- OIL States Energy…
OIL States Energy Services, L.L.C.
35 patents
- Osstem Implant
Osstem Implant Co., Ltd
35 patents
- Other LAB
Other LAB, LLC
35 patents
- P&W Solutions
P&W Solutions Co., Ltd.
35 patents
- Panasonic Semicon…
Panasonic Semiconductor Solutions Co., Ltd.
35 patents
- Pari Pharma
Pari Pharma GmbH
35 patents
- Pluto
Pluto Inc.
35 patents
- Occlutech ◀
Occlutech GmbH
35 patents
What this shows Occlutech holds 35 patents at rank #9,098, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Occlutech
By rank, the assignees closest to #9,098 in granted patent volume.
- NeuroNexus Technologies, Inc. #9,094 · 35 patents
- OIL States Energy Services, L.L.C. #9,095 · 35 patents
- Osstem Implant Co., Ltd #9,096 · 35 patents
- Other LAB, LLC #9,097 · 35 patents
- P&W Solutions Co., Ltd. #9,099 · 35 patents
- Panasonic Semiconductor Solutions Co., Ltd. #9,100 · 35 patents
- Pari Pharma GmbH #9,101 · 35 patents
- Pluto Inc. #9,102 · 35 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Occlutech's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Occlutech, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Occlutech ranks #624 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (42 here).
Occlutech's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
42 Top 30% higher than 70% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 14.3% |
| 2016 | 5 | 14.3% |
| 2017 | 5 | 14.3% |
| 2018 | 5 | 14.3% |
| 2020 | 3 | 8.6% |
| 2021 | 2 | 5.7% |
| 2022 | 2 | 5.7% |
| 2023 | 4 | 11.4% |
| 2024 | 1 | 2.9% |
| 2025partial year | 3 | 8.6% |
Which technologies does Occlutech GmbH patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Occlutech GmbH's patent record in context - here's where to go next.
- Occlutech GmbH's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 85.7% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #9,097 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Occlutech GmbH against NeuroNexus Technologies, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 42.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.